We sought to assess the effect of progestin on the apoptosis of epithelial ovarian cancer cell line SKOV-3 and via regulation of phosphorylation signaling in. Epithelial ovarian cancer cell line SKOV-3 was treated with medroxyprogestogen, phosphatidylinositol 3-kinase inhibitor LY294002 and vehicle control. Akt, phospho-Akt, Bcl-2 and phospho-Bad proteins were examined by immunoblotting assays. Medroxyprogestogen-induced apoptosis was assessed by MTT assays and Annexin V apoptosis assay. We found no significant difference in Akt and Bad expression in both the medroxyprogestogen groups and the control group. The levels of phospho-Akt, Bcl-2 and phospho-Bad were decreased in all the medroxyprogestogen groups and significantly decreased in the high dose mitogen-activated protein (MAP) group (10 µmol/L). Viability of SKOV-3 was reduced and apparent apoptosis of SKOV-3 cells was observed with increased doses of MAP. The findings suggest that medroxyprogestogen can induce SKOV-3 cell apoptosis by inhibiting Akt phosphorylation.
Medroxyprogestogen enhances apoptosis of SKOV-3 cells via inhibition of the PI3K/Akt signaling pathway
Yan Li,Yi Jiang,Y. Wan,Lin Zhang,Weiwei Tang,Jingjing Ma,Shan Wu,Wenjun Cheng
Published 2012 in Journal of Biomedical Research
ABSTRACT
PUBLICATION RECORD
- Publication year
2012
- Venue
Journal of Biomedical Research
- Publication date
2012-12-10
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
CONCEPTS
- apoptosis
Programmed cell death measured as an outcome in the assays.
- bcl-2
An anti-apoptotic Bcl-2 family protein measured by immunoblotting.
- medroxyprogestogen
A progestin compound administered to SKOV-3 cells in the experiment.
Aliases: MAP
- pi3k/akt signaling pathway
A cell signaling pathway involving PI3K and Akt that was examined in the study.
Aliases: phosphatidylinositol 3-kinase/Akt signaling pathway
- skov-3 cell line
A human epithelial ovarian cancer cell line used as the experimental model.
REFERENCES
Showing 1-30 of 30 references · Page 1 of 1
CITED BY
Showing 1-25 of 25 citing papers · Page 1 of 1